Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)

CNY 4.78

(-0.21%)

Market Cap (In CNY)

4.8 Billion

Revenue (In CNY)

3.62 Billion

Net Income (In CNY)

-43.98 Million

Avg. Volume

23.06 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.13-7.12
PE
-
EPS
-
Beta Value
0.406
ISIN
CNE100000YR9
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Lianmin Yang
Employee Count
-
Website
https://www.zdjt.com
Ipo Date
2011-01-07
Details
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers cancer drugs, cardiovascular drugs, infectious disease drugs, and respiratory drugs; antibiotics, antitumor drugs, vitamins, etc.; Chinese medicines; calcium preparations; and active pharmaceutical ingredients, as well as sells gastrointestinal drugs. The company offers its products in various dosage forms, such as large volume injections, small volume injections, powder injections, lyophilized powders, tablets, hard capsules, granules, dry suspensions, ointments, psychotropic substances, and other formulations Shanxi Zhendong Pharmaceutical Co.,Ltd is based in Changzhi, China.